GUIDED THERAPEUTICS INC Quarterly Net Cash Provided by (Used in) Financing Activities in USD from Q1 2011 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Guided Therapeutics Inc quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from Q1 2011 to Q1 2024.
  • Guided Therapeutics Inc Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2024 was -$46K, a 300% decline year-over-year.
  • Guided Therapeutics Inc annual Net Cash Provided by (Used in) Financing Activities for 2023 was $24K, a 99.2% decline from 2022.
  • Guided Therapeutics Inc annual Net Cash Provided by (Used in) Financing Activities for 2022 was $3.18M, a 53.8% increase from 2021.
  • Guided Therapeutics Inc annual Net Cash Provided by (Used in) Financing Activities for 2021 was $2.07M, a 78.3% increase from 2020.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 -$46K -$69K -300% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q1 2023 $23K -$252K -91.6% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q1 2022 $275K -$1.11M -80.2% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q1 2021 $1.39M +$1.73M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q1 2020 -$348K -$540K -281% Jan 1, 2020 Mar 31, 2020 10-Q/A 2021-08-18
Q1 2019 $192K -$278K -59.1% Jan 1, 2019 Mar 31, 2019 10-Q 2020-07-07
Q1 2018 $470K +$76K +19.3% Jan 1, 2018 Mar 31, 2018 10-Q 2019-07-11
Q1 2017 $394K -$582K -59.6% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-21
Q1 2016 $976K +$494K +102% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-22
Q1 2015 $482K +$82K +20.5% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-19
Q1 2014 $400K -$1.08M -73% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-13
Q1 2013 $1.48M +$1.36M +1093% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-15
Q1 2012 $124K -$3K -2.36% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-14
Q1 2011 $127K Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.